financetom
Business
financetom
/
Business
/
Viatris eye therapy fails to meet late-stage trial goal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viatris eye therapy fails to meet late-stage trial goal
Jul 18, 2025 4:24 AM

July 18 (Reuters) - Viatris ( VTRS ) said on Friday that

its experimental ophthalmic ointment did not meet the main goal

of a late-stage study in patients with an eye condition that

causes inflammation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved